Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis
European Archives of Psychiatry and Clinical Neuroscience · 2025-08 · 275 (5) · 1359-1371
DOI: 10.1007/s00406-024-01920-x ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, online erschienen am 09.10.2024. Verfasst von Jiafeng Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Antidepressive Agents, Bipolar Disorder, Ketamine, Suicidal Ideation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
The current systematic review and meta-analysis examined the effect of racemic ketamine or esketamine on suicidal ideation in individuals with uni- or bipolar depression. We searched the MEDLINE, Embase, Central, PsycINFO, and Web of Science databases to identify randomized controlled trials that examined the effect of racemic ketamine or esketamine monotherapy on suicidal ideation (SI) in individuals with uni- or bipolar depression. The two monotherapies were compared; the primary outcome was the rate of remission of SI, and the secondary outcome was the SI score. The risk ratio was used as an effect size measure for binary variables, while the standardized mean difference was used as an effect size measure for continuous variables. Our meta-analysis included 13 randomized controlled trials involving 1,1109 individuals with uni- or bipolar depression. Patients receiving racemic ketamine monotherapy had a significantly higher acute SI remission rate than those receiving placebo or midazolam (RR = 2.06, 95% CI 1.47 to 2.91, P < 0.0001). Racemic ketamine also led to significantly lower SI scores than placebo or midazolam (SMD = -0.36, 95% CI -0.71 to -0.01, P = 0.04). The evidence for the treatment of SI with esketamine was inconsistent. The pooled effect sizes for long-term anti-SI effects did not reveal significant differences between therapies. Our study indicated the efficacy of racemic ketamine monotherapy for rapidly and transiently reducing SI in individuals with uni- or bipolar depression, but the efficacy of racemic ketamine monotherapy against long-term suicidal ideation remains unclear. There is not -sufficient evidence to support the anti-suicidal effects of esketamine monotherapy.Protocol registration: Prospero registration number: CRD42023434380.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mental Health Center, West China Hospital of Sichuan University, Chengdu, China.
- Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
- Center for Intervention and Research on adaptive and maladaptive brain Circuits underlying mental health (C-I-R- C), Halle-Jena-Magdeburg, Germany.
- Clinical Affective Neuroimaging Laboratory (CANLAB), Leipziger Str. 44, Building 65, 39120, Magdeburg, Germany.
- President's Office, West China Hospital of Sichuan University, Chengdu, China.
- Mental Health Center, West China Hospital of Sichuan University, Chengdu, China. xujiajun120@126.com.
Zitieren
APA
Li, J., Ma, L., Sun, H., Li, M., Cao, Y., Peng, Y., & Xu, J. (2025). Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 275(5), 1359-1371. https://doi.org/10.1007/s00406-024-01920-x
Vancouver
Li J, Ma L, Sun H, Li M, Cao Y, Peng Y, et al. Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(5):1359-1371. doi:10.1007/s00406-024-01920-x
BibTeX
@article{Li2025,
author = {Li, Jiafeng and Ma, Ling and Sun, Huan and Li, Meng and Cao, Yuan and Peng, Yang and Xu, Jiajun},
title = {Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis},
journal = {European Archives of Psychiatry and Clinical Neuroscience},
year = {2025},
volume = {275},
number = {5},
pages = {1359--1371},
doi = {10.1007/s00406-024-01920-x}
}
EUVIMED